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SUMMARY   10 
This study aimed to evaluate survival of dogs with degenerative mitral valve disease 11 
(DMVD). A retrospective cohort study of dogs with DMVD attending primary-care practices 12 
in England was undertaken. Cases of DMVD were identified within the electronic patient 13 
records (EPRs) of practices sharing data with VetCompass. Kaplan-Meier curves were used to 14 
explore survival and Cox regression models identified factors associated with hazard of death.  15 
The EPRs from 111,967 dogs, attending 93 veterinary practices between January 2010 and 16 
December 2011 identified 405 cases diagnosed with DMVD giving a prevalence of diagnosed 17 
DMVD of 0.36% (95% CI: 0.29 – 0.45%). A further 3,557 dogs were classified as possible 18 
cases (heart murmurs consistent with DMVD). Overall, a total of 3,962 dogs were classified as 19 
heart murmur cases (possible and diagnosed DMVD), giving a prevalence of 3.54% (95% CI: 20 
3.26 – 3.84%).  21 
One hundred and sixteen (28.6%) of the diagnosed DMVD cases were incident, newly 22 
diagnosed with DMVD. The mean age at diagnosis was 9.52 years (95% CI: 8.98 – 10.14 23 
years). Fifty-eight (50.0%) of the incident cases died during the study period. The median 24 
survival time (MST) for all-cause mortality was 25.4 months (95% CI: 20.4 – 34.4 months) 25 
after disease detection for DMVD cases. For possible cases, 121 (29.7%) from a random 26 
sample of 407 possible DMVD cases were incident cases (newly detected heart murmur 27 
consistent with DMVD during the study period). The mean age at which a heart murmur was 28 
first recorded in possible cases was 9.73 years (95% CI: 9.02 – 10.44 years). Forty-nine 29 
(40.5%) possible cases died during the study period. The MST for all-cause mortality was 33.8 30 
months (95% CI: 23.7 – 43.1 months) after a heart murmur was initially detected. In the 31 
multivariable survival analysis for possible and diagnosed cases, Cavalier King Charles 32 
Spaniels (CKCSs) and other purebreds had higher hazards of death than crossbreds. Dogs 33 
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weighing ≥ 20.0 kg and older dogs had an increased hazard of death compared with those < 34 
20.0 kg and younger dogs, respectively.  35 
The study highlights poorer survival for all-cause mortality in CKCSs and larger dogs. The 36 
reported survival characteristics could aid veterinary surgeons’ advice on the prognosis for 37 
dogs with DMVD and help the assessment of the impact of the condition at a population level. 38 
KEY WORDS epidemiology, primary-care practice, cardiac, survival, canine 39 
INTRODUCTION 40 
Degenerative mitral valve disease (DMVD) has a high prevalence in the domestic dog 41 
population, with estimates ranging between 3.5% - 69.7% (Detweiler & Patterson, 1965; 42 
Whitney, 1974; Thrusfield et al., 1985). The disorder is generally straightforward to diagnose 43 
from the presence of a characteristic heart murmur (Borgarelli & Haggstrom, 2010). However, 44 
dogs with DMVD form a heterogeneous population and only a proportion of affected animals 45 
will develop congestive heart failure or die as a result of their cardiac disease (Borgarelli et al., 46 
2012). Hence a major challenge for practitioners centres on prognostication and identifying 47 
patients at greater risk of death.   48 
Survival times have been reported for cohorts of dogs with DMVD recruited to clinical trials 49 
(Ettinger et al., 1998; The Bench Study Group, 1999; Haggstrom et al., 2008) and those 50 
included in observational studies monitored by specialist veterinary cardiologists (Borgarelli 51 
et al., 2008; Moonarmart et al., 2010; Borgarelli et al., 2012; Hezzell et al., 2012). Data from 52 
specialist-treated populations may be poorly generalizable to wider DMVD populations 53 
because referral caseloads may include complex cases requiring more advanced care (Bartlett 54 
et al., 2010) and non-consent bias may occur if patients enrolled into clinical trials are not 55 
representative of  more general populations (Marcus, 1997). Further, the time of entry into 56 
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existing survival studies was generally defined as the time of referral or randomization, rather 57 
than the time the disease was initially detected, limiting the application of these results to the 58 
primary-care setting. The current literature on primary-care practice populations of dogs with 59 
DMVD lacks median survival time (MST) estimates from the time of disease detection to time 60 
of death.  61 
Risk stratification could improve prognosis and management of DMVD cases. For example, 62 
more frequent monitoring or targeted therapy may be warranted in patients at high risk of 63 
progressive disease (Hezzell et al., 2012). Previous survival studies have largely focussed on 64 
the predictive value of echocardiographic and radiographic measurements (Haggstrom et al., 65 
2008; Moonarmart et al., 2010; Lord et al., 2011; Borgarelli et al., 2012; Hezzell et al., 2012; 66 
Reynolds et al., 2012) and circulating concentrations of cardiac biomarkers (Fonfara et al., 67 
2010; Moonarmart et al., 2010; Hezzell et al., 2012; Eriksson et al., 2014) in dogs with DMVD. 68 
However, in primary-care practice, these diagnostic tests are often omitted due to limited 69 
availability of equipment, lack of clinical expertise or financial constraints. Some of these 70 
studies also evaluated the prognostic value of demographic variables, such as sex, breed, age 71 
and bodyweight (Haggstrom et al., 2008; Moonarmart et al., 2010; Hezzell et al., 2012; 72 
Reynolds et al., 2012), which can be easily derived from primary-care data. However, the latter 73 
studies yielded conflicting results and may have limited external validity as their study 74 
populations were managed by specialist veterinary cardiologists, which may be subject to 75 
selection bias.  76 
Estimating MST and evaluating the predictive value of demographic factors in the primary-77 
care setting would be of value as these results would be relevant to the wider primary-care 78 
population and could aid prognostication. The objectives of this study were to estimate the 79 
MST of dogs with DMVD and to identify demographic risk factors associated with all-cause 80 
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mortality in affected animals attending primary-care veterinary practices in England. It was 81 
hypothesised that crossbred dogs would have a lower hazard of death than purebred dogs.  82 
MATERIALS AND METHODS 83 
A retrospective cohort study followed cases of DMVD identified within the electronic 84 
patient records (EPRs) of dogs attending veterinary practices sharing de-identified data with 85 
the Veterinary Companion Animal Surveillance System database (VetCompass, 2014) between 86 
1st January 2010 and 31st December 2011. The practices were primary-care companion animal 87 
practices, both independent and corporate, that had been recruited via publication of letters 88 
requesting participation of interested practices in the veterinary press and journals, regional 89 
meeting and presentations, and in response to enquiries from practices themselves. They were 90 
mainly located in central and southeast England. Data shared included demographic (date of 91 
birth, sex, breed, bodyweight, insurance status, microchip number, partial postcode, veterinary 92 
practice ID) and clinical data (free-text clinical notes, VeNom diagnostic terms (VeNom 93 
Coding Group, 2014), and treatments prescribed). The study received ethics approval from the 94 
Royal Veterinary College ethics and welfare committee. 95 
Case finding was achieved by searching for EPRs containing key diagnostic terms relating 96 
to DMVD (e.g. ‘mitral’, ‘valv*’, ‘MVD’, ‘murm*’) and reviewing the free text clinical notes 97 
of potential cases. Two case definitions were developed to account for different levels of 98 
diagnosis: diagnosed DMVD and possible DMVD cases. Diagnosed DMVD cases were 99 
defined as dogs with a stated diagnosis of DMVD (or synonym) in their clinical notes or 100 
VeNom diagnostic terms. Possible DMVD cases were defined as dogs over one year old with 101 
a documented heart murmur consistent with DMVD without a specific cardiac diagnosis. Dogs 102 
reported to have continuous or diastolic murmurs were excluded as cases. Dogs with murmurs 103 
that had only been detected during pregnancy or that presented with other clinically significant 104 
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systemic disease (e.g. moderate to severe anaemia, pyrexia, severe hypovolaemia or 105 
dehydration) were also excluded. Dogs reported to have murmurs or mitral valve regurgitation 106 
due to other diagnosed cardiac disorders (e.g. aortic stenosis, ventricular septal defects etc.) 107 
were additionally excluded. Where a murmur was recorded and no evidence of any of the above 108 
criteria for exclusion was documented, the dog was classified as a possible DMVD case. 109 
Evidence of a point of maximal intensity (thoracic location where the heart murmur is heard 110 
most loudly) inconsistent with DMVD on chest auscultation was not used as an exclusion 111 
criterion. Diagnosed and possible DMVD cases were combined to form a population of dogs 112 
with heart murmurs consistent with DMVD for the prevalence estimates, hereafter described 113 
as heart murmur cases. Incidence estimates were reported separately for possible and diagnosed 114 
cases. 115 
The EPRs of all diagnosed cases up to May 2014 were examined in detail. The date of the 116 
first veterinary consultation, the date the disease was detected and the date, cause and modality 117 
of death were extracted, where applicable. Incident cases were defined as dogs that were newly 118 
diagnosed with DMVD or recorded with a heart murmur during the study period. Dogs alive 119 
at the end of the study period were censored on the date of the last entry in their clinical notes.  120 
Death as a result of cardiac disease (cardiac death) was defined as euthanasia or death due to 121 
worsening of clinical signs associated with DMVD or when veterinary surgeons stated that 122 
heart disease was the primary cause of death in the clinical notes. Cases were not classified as 123 
cardiac deaths if alternative or multiple causes of death were listed, or if the cause of death was 124 
not specified. Due to the large number of possible cases and the time required to review each 125 
case’s clinical records, a random sample of possible DMVD cases was selected from the 126 
denominator of all possible cases using an electronic random number generator 127 
(www.random.org) to enable comparison between the survival of diagnosed and possible cases. 128 
The number of possible cases randomly selected was based on providing a similar number of 129 
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cases as evaluated for the diagnosed cases in order to provide a similar level of statistical power 130 
to detect major risk factors. The date of murmur detection and the date, cause and modality of 131 
death in incident possible cases were recorded. 132 
Data were exported to a spreadsheet (Microsoft Office Excel 2010, Microsoft Corp, 133 
Redmond, WA), checked, cleaned and exported to Stata Version 13 (Stata Corporation, TX) 134 
for analysis. Prevalence and 95% confidence intervals (95% CI) were calculated for heart 135 
murmur cases (including both diagnosed and possible cases) and for diagnosed DMVD cases 136 
only. Prevalence was adjusted for clustering at the practice level using survey commands 137 
(StataCorp., 2013). Further analyses relate to incident cases only. 138 
The MST for all-cause mortality and cardiac death were calculated for diagnosed and 139 
possible cases, when possible. Kaplan-Meier survival curves were generated for all-cause 140 
mortality and cardiac-related death and log-rank tests were used to explore survival differences 141 
between diagnosed and possible cases. Univariable and multivariable Cox proportional hazard 142 
models were used to evaluate associations between the following explanatory variables and 143 
hazard of death (all-cause mortality): breed, sex, insurance status, maximum recorded 144 
bodyweight (kg), age at diagnosis (years) and level of diagnosis (diagnosed and possible cases). 145 
Breeds were categorised into ‘crossbred’, ‘Cavalier King Charles Spaniel’ (CKCS) and ‘other 146 
purebred’. CKCS were evaluated as a separate group as this represented the most common 147 
breed within the data and has frequently been a comparator group in the current literature 148 
(Haggstrom et al., 2008). Additional analyses evaluating a binary breed variable (‘purebreds’ 149 
and ‘crossbreds’) were performed. Maximum bodyweight was further dichotomised based on 150 
published literature (< 20.0 kg and ≥ 20.0 kg) (Borgarelli et al., 2004; Borgarelli et al., 2012). 151 
Age at diagnosis (years) was categorised into four groups (< 5.0, 5.0 - < 10.0, 10.0 - < 15.0, 152 
and ≥ 15.0 years) and evaluated for a linear trend association. Level of diagnosis and breed 153 
8 
 
were forced variables in the model to account for the sampling technique and a priori interest, 154 
respectively. Variables significant at the 20% level in univariable analyses were taken forward 155 
for consideration in the mixed effects multivariable model. Manual stepwise backward 156 
elimination regression was used to sequentially remove variables with a P-value > 0.05 in the 157 
multivariable model (Dohoo et al., 2009). Each eliminated variable was then added to the final 158 
model to assess for important confounding by the change in parameter estimates. First order 159 
interactions between final model explanatory variables were evaluated. Veterinary practice was 160 
evaluated as a shared frailty term to account for clustering at the practice-level. The 161 
proportional hazards assumption was tested using Schoenfeld residuals and visual inspection 162 
of log-cumulative hazard and Kaplan-Meier Cox plots. Goodness of fit was evaluated using 163 
Cox-Snell residuals. Dogs with any missing data for the risk factors of interest were excluded 164 
from the multivariable Cox proportional hazards model.   165 
It was estimated that a sample size of approximately 160 individuals would be required to 166 
detect a hazard ratio (HR) for all-cause mortality of two for a variable to which 75% of 167 
individuals were exposed, at a confidence level of 95% and power of 80%. This calculation 168 
was based on the estimated proportion of purebred dogs in the VetCompass database (O'Neill 169 
et al., 2014), an accrual time of 24 months, a follow-up time of 24 months and a MST of 20 170 
months for exposed individuals (PS Power and Sample Size Calculations, 2014).  171 
RESULTS  172 
Descriptive statistics 173 
The denominator population consisted of 111,967 individual dogs attending 93 veterinary 174 
practices on one or more occasions between 1st January 2010 and 31st December 2011. Four 175 
hundred and five dogs were identified as having a diagnosis of DMVD, giving a prevalence, 176 
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adjusted for the clustering effect of practice, of 0.36% (95% CI: 0.29 – 0.45%).  A further 3,557 177 
dogs were classified as possible cases, having a heart murmur consistent with DMVD recorded 178 
within their EPRs. Generally, the age, bodyweight and breed distributions of possible and 179 
diagnosed DMVD cases were similar; with DMVD typically affecting older small- to medium-180 
sized dogs (data not shown). A total of 3,962 dogs were heart murmur cases (with possible or 181 
diagnosed DMVD), giving a prevalence, adjusted for the clustering effect of practice, of 3.54% 182 
(95% CI: 3.26 – 3.84%).   183 
 184 
Survival times of incident diagnosed and possible DMVD cases 185 
Incident diagnosed DMVD cases: One hundred and sixteen (28.6%) of the 405 diagnosed 186 
DMVD cases were incident cases, newly diagnosed with DMVD or recorded with a heart 187 
murmur during the study period. The mean age at which DMVD was diagnosed or the presence 188 
of a heart murmur was first recorded in diagnosed cases was 9.52 years (95% CI: 8.98 – 10.14 189 
years). The median follow-up time was 17.9 months (IQR: 6.0 – 27.9 months, range: 0.0 – 45.2 190 
months). Fifty-eight (50.0%) of the 116 incident diagnosed cases died during the study period. 191 
Twenty of these 58 (34.5%) deaths were primarily due to cardiac disease, 9 (15.5%) deaths 192 
occurred due to multiple causes including cardiac disease and 16 (27.6%) deaths occurred due 193 
to non-cardiac causes. In 13 (22.4%) cases, cause of death was not recorded. Euthanasia 194 
accounted for 43 (74.1%) of the 58 deaths. The MST for all-cause mortality was 25.4 months 195 
(95% CI: 20.4 – 34.4 months) after the disease was initially detected (Table 1). MST for cardiac 196 
death could not be calculated for these cases as the cumulative proportion of dogs surviving 197 
failed to drop below 0.5.  198 
Incident possible DMVD cases: One hundred and twenty one (29.7%) from a random 199 
sample of 407 possible DMVD cases were incident cases, based on the presence of a heart 200 
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murmur consistent with newly detected DMVD during the study period. The mean age at which 201 
the presence of a heart murmur was first recorded in possible cases was 9.73 years (95% CI: 202 
9.02 – 10.44 years). The median follow-up time for possible cases was 14.4 months (IQR: 2.5 203 
– 27.6 months, range 0.0 – 43.5 months). Forty-nine (40.5%) possible cases died during the 204 
study period. Eight (16.3%) of the 49 deaths were primarily attributed to cardiac disease, two 205 
(4.1%) deaths occurred due to multiple causes including cardiac disease and 29 (59.2%) deaths 206 
occurred due to non-cardiac causes. In 10 (20.4%) of the 49 cases that died, cause of death was 207 
not recorded. Euthanasia accounted for 45 (91.2%) of the 49 deaths. The MST for all-cause 208 
mortality was 33.8 months (95% CI: 23.7 – 43.1 months) after a heart murmur was initially 209 
detected.  MST for cardiac related death was 42.0 months (95% CI: 31.2 – 52.7 months). There 210 
was no evidence of a significant difference in the survival functions of diagnosed and possible 211 
DMVD cases for all-cause mortality (log rank test, P = 0.63) (Fig. 1). However, there was a 212 
statistically significant reduction in survival for cardiac mortality for diagnosed compared to 213 
possible cases (log rank test, P = 0.034) (Fig. 2). 214 
Cox proportional hazards models: In the univariable analysis, there was a non-statistically 215 
significant trend for an association between breed and survival (P = 0.083). CKCS had a lower 216 
hazard of death than crossbred dogs (HR 0.44, 95% CI 0.21 – 0.96), whereas there was no 217 
difference observed between the survival of crossbreds and other purebreds. Dogs with a 218 
maximum recorded bodyweight of 20.0 kg or greater had almost twice the hazard of death in 219 
the univariable analysis (HR 1.87, 95% CI: 1.24 – 2.83). For each 5-year category increase in 220 
age, the hazard of death increased by a factor of 2.80 (95% CI: 2.09 – 3.75). There was no 221 
evidence of an association between survival and sex, insurance status or level of diagnosis 222 
(diagnosed versus possible cases) (Table 2). When CKCS were combined with other purebreds, 223 
no association between breed and survival was detected (P = 0.245). Twelve dogs had missing 224 
bodyweight data and 10 dogs did not have insurance status recorded. 225 
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 227 
In the multivariable analysis, CKCS (HR 2.78, 95% CI: 1.05 – 7.36) and other purebred 228 
dogs (HR 1.86, 95% CI: 1.07 – 3.23) had a higher hazard of death than crossbred dogs. Dogs 229 
weighing ≥ 20.0 kg had almost three times the hazard of death than dogs < 20.0 kg (HR 2.81, 230 
95% CI: 1.72 – 4.59). For each 5-year age category increase, hazard of death increased 3.85 231 
fold (95% CI: 2.61 – 5.69). Veterinary practice was included as a shared frailty term (P = 232 
0.027). No major confounding (as represented by substantial variation in hazard ratios on 233 
addition of the second variable) or statistically significant interactions were identified. There 234 
was no evidence that the proportional hazards assumption was violated and the model 235 
diagnostics showed no evidence of lack of fit. When the breed variable with three groups 236 
(CKCS, other purebreds and crossbreds) was substituted for the binary breed variable 237 
(purebreds and crossbreds) in the multivariable model, the association between breed and 238 
survival persisted; with purebreds having approximately double the hazard of death compared 239 
with crossbred dogs (HR 1.84, 95% CI: 1.06 – 3.18). 240 
 241 
DISCUSSION 242 
This study identified a prevalence of diagnosed DMVD of 0.36% (95% CI: 0.29 – 0.45%) 243 
and a substantially greater proportion of dogs with heart murmurs consistent with DMVD 244 
(3.54%, 95% CI: 3.26 – 3.84%). The MST following detection of the disease was 245 
approximately 2 – 3 years in both diagnosed and possible DMVD cases. Purebreds, older dogs 246 
and those weighing ≥ 20.0 kg had a higher hazard of death compared with crossbreds, younger 247 
and lighter dogs, respectively.  248 
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The MSTs for all-cause mortality were 25.4 (95% CI: 20.4 – 34.4) and 33.8 (23.7 – 43.1) 249 
months for diagnosed and possible cases, respectively. Considering that the disease was 250 
initially detected in older dogs (mean age 9.52 and 9.73 years in diagnosed and possible cases, 251 
respectively) and the MST was relatively long, DMVD appeared to have minimal impact on 252 
longevity in many dogs. Further, the median age of death in our DMVD cohort was 12.2 years 253 
(IQR: 10.5 – 14.3 years), similar to median longevity reported for 5,095 dogs with confirmed 254 
deaths within the VetCompass population (12.0 years, IQR 8.9 – 14.2 years) (O'Neill et al., 255 
2013). The median age of death of crossbreds (14.3 years, IQR: 12.3 – 15.2), purebreds (11.7 256 
years, IQR: 10.0 – 13.6) and CKCS (10.0 years, IQR 8.6 – 10.7) in the current DMVD cohort 257 
were similar to those reported within the overall VetCompass population (13.1 years, IQR: 258 
10.1 – 15.0; 11.9 years, IQR 8.4 – 14.0 and 9.9 years, IQR 8.1 – 12.3, respectively) (O'Neill et 259 
al., 2013). However, 34.5% of deaths among dogs with diagnosed DMVD were primarily due 260 
to their cardiac disease, emphasising that dogs with DMVD are a heterogeneous population 261 
and that it is therefore important to identify those most at risk of progressive disease and death. 262 
When only cardiac related deaths were considered, dogs with diagnosed DMVD had shorter 263 
survival times than possible cases. Given the age at detection of murmurs and disease in 264 
possible and diagnosed cases respectively were very similar and the shorter survival times of 265 
diagnosed DMVD cases, it would appear that dogs with more advanced cardiac disease may 266 
be more likely to receive a diagnosis and be classified as diagnosed DNVD and die sooner due 267 
to their more severe state of disease.  268 
The estimated MST in the current study was generally longer than those reported in the 269 
literature. Two studies evaluating survival in dogs presenting to Italian referral centres reported 270 
MST of approximately 20 months for all-cause mortality (Borgarelli et al., 2008, Borgarelli et 271 
al., 2012). A cohort of dogs with DMVD enrolled to a research clinic in the UK had a MST of 272 
11.1 months (range 0.1 – 32.7 months) (Moonarmart et al., 2010). Randomised controlled trials 273 
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evaluating different interventions in dogs with heart failure due to DMVD have reported MST 274 
from the time of randomisation until cardiac death or treatment failure. In the BENCH study, 275 
MST was 14.5 months in the intervention group and 5.0 months in the placebo group (The 276 
Bench Study Group, 1999). MST for dogs recruited to the LIVE and QUEST studies were 277 
approximately 5 - 6 months (Ettinger et al., 1998; Haggstrom et al., 2008). The discrepancies 278 
between the MST reported in the current study and those published in the literature may be due 279 
to differing inclusion criteria and primary end-points. The current study included dogs at all 280 
stages of the disease and the primary-end point was death, whereas some previous studies 281 
focused only on dogs with congestive heart failure and, for ethical reasons, included treatment 282 
failure among their primary end-points. A delay between disease detection by the primary-care 283 
practitioner and subsequent referral for inclusion into survival studies may also account for 284 
MST differences. Moreover, referral populations may be prone to preferentially select dogs 285 
with more advanced disease (Bartlett et al., 2010) than the entire canine DMVD population. 286 
The MSTs reported by the current study may thus be of greater relevance to primary-care 287 
practitioners, who manage most DMVD cases. 288 
Cavalier King Charles Spaniels (HR 2.78, 95% CI: 1.05 – 7.36) and other purebred dogs 289 
(HR 1.86, 95% CI: 1.07 – 3.23) had a higher hazard of death than crossbred dogs in the 290 
multivariable analysis. Interestingly, in the univariable analysis, CKCS had a significantly 291 
decreased hazard of death (HR 0.44, 95% CI: 0.21 – 0.96) and purebreds had a similar hazard 292 
of death compared with crossbreds. The differences between the results of univariable and 293 
multivariable analyses were largely due to the confounding effect of age at diagnosis; CKCS 294 
and other purebreds were significantly younger when they developed DMVD compared with 295 
crossbred dogs and, after adjusting for age at diagnosis, the trend to reduced hazard in the 296 
purebred categories disappeared and these breeds were associated with increased hazard of 297 
death. 298 
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In the current study, dogs weighing 20 kg or more had nearly three times the hazard of death 299 
compared with dogs less than 20 kg (HR 2.81, 95% CI: 1.72 – 4.59). It has been suggested that 300 
heavier dogs and larger breed types with primary mitral valve disease may have a different 301 
clinical course compared with smaller dogs (Borgarelli et al., 2004). An alternative explanation 302 
for the association between survival and bodyweight in the current study population is that 303 
heavier dogs were more likely to be misclassified as DMVD cases. It is possible that some of 304 
these dogs had heart murmurs due to other causes, such as dilated cardiomyopathy, which is 305 
more common in large breeds and carries a poorer prognosis than DMVD (Martin et al., 2009). 306 
Finally, population-based studies consistently report that larger dogs have reduced longevity 307 
compared with smaller dogs (Michell, 1999; Galis et al., 2007; Greer et al., 2007; O'Neill et 308 
al., 2013). As the multivariable analysis in the current study explored only all-cause mortality, 309 
the association between bodyweight and hazard of death may reflect reduced longevity in 310 
general in larger dogs rather than cardiac deaths specifically.  311 
In agreement with a previous study (Hezzell et al., 2012), there was strong evidence for an 312 
association between age and all-cause mortality in dogs with DMVD, with hazard of death 313 
increasing 3.85 fold (95% CI: 2.61 – 5.69) for each 5 year increase in age at diagnosis. In 314 
addition to being an independent predictor of outcome, age at diagnosis confounded the 315 
associations between breed and hazard of death, highlighting the importance of multivariable 316 
analyses when interpreting the effect of explanatory variables in epidemiological studies.   317 
Including veterinary practice as a shared frailty term improved model fit, suggesting that 318 
practice-level factors influenced the outcome. The type of treatment administered has been 319 
reported to influence survival of dogs with DMVD (The Bench Study Group, 1999; Haggstrom 320 
et al., 2008), so if therapeutic management of cases within a practice are more similar than 321 
between practices, the survival experience of individuals attending the same practice may be 322 
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more similar than those of individuals from different practices. Further, most deaths resulted 323 
from euthanasia, rather than unassisted death. A poor prognosis given by the attending 324 
veterinary practitioner was identified as an important factor influencing the decision to 325 
euthanase dogs with congestive heart failure (Mallery et al., 1999). The timing of death may 326 
therefore be influenced by human factors and highlights the importance of optimising 327 
evidence-based prognostic guidelines.  328 
This study had several limitations. Data were not originally recorded for research purposes 329 
but for clinical and billing reasons and were analysed retrospectively. Retrospective searching 330 
of the clinical records for key DMVD diagnostic terms may have missed some cases (false 331 
negatives) and incorrectly classified as positive others (false positives). In relation to specificity 332 
of search terms, this limitation was addressed by reviewing clinical records relating to a dog to 333 
minimise misclassification of non-DMVD dogs as cases. With regard to maximising 334 
sensitivity, the search strategy used was relatively broad (including use of truncated versions 335 
of key terms to allow for mis-spelling) and for DMVD a limited number of clinical terms are 336 
generally used by veterinary surgeons in practice, though inevitably some cases may have been 337 
missed. Further, if a practitioner did not perform thoracic auscultation or transcribe the DMVD 338 
diagnosis or the presence of a heart murmur into the EPR, an affected dog would fail to be 339 
included as a case. In a recent study of clinical examination behaviour in practice, Robinson 340 
and colleagues (2014) reported that only 59% of dogs received a full clinical examination and 341 
a further 33% had focused clinical examinations only, suggesting thoracic auscultation may 342 
not always be routinely performed. As such, especially where there appear to be minimal 343 
clinical signs of cardiac disease, thoracic auscultation may be less likely to be performed and 344 
the prevalence of disease, possible cases in particular, may have been underestimated. Equally, 345 
individuals with heart murmurs due to other causes could have been misclassified as possible 346 
cases, as a definitive diagnosis of DMVD requires echocardiographic confirmation (Borgarelli 347 
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& Buchanan, 2012). Further, based on the case definition, if excludable criteria were detected 348 
by the veterinary surgeon but not recorded in the clinical records, these dogs would have been 349 
misclassified as cases. However, the presence of a left apical systolic heart murmur in a dog of 350 
typical signalment is highly suggestive of DMVD (Borgarelli & Haggstrom, 2010). Further, 351 
the breed, age and bodyweight distributions of possible and diagnosed cases were similar, 352 
suggesting that most of the possible cases were as likely to have DMVD as those diagnosed by 353 
the attending veterinarian. Nonetheless, the prevalences reported must remain estimates at best, 354 
of the frequency of DMVD in dogs presenting to veterinary practices. Secondly, the current 355 
study evaluated only factors associated with hazard of death for all-cause mortality. However, 356 
within the all-cause mortality group, based on the pre-study power calculations, the number of 357 
cases identified substantially exceeded the calculation requirements, suggesting the study had 358 
ample power to detect biologically meaningful associations with hazard ratios of 2 or above.  359 
A higher powered study evaluating both all-cause and cardiac related mortality, 360 
notwithstanding the additional resources implications of reviewing an expanded body of 361 
clinical records, could help further elucidate the identified associations. Finally, it is important 362 
to acknowledge that the current study was of a convenience sample of corporate and 363 
independently owned, exclusively companion animal veterinary practices. Nonetheless, data 364 
were from just under 100 practices distributed across England (approximately 2% of RCVS 365 
registered veterinary practices), so the main conclusions are likely to be relevant for the 366 
practice-attending dog population in the UK. 367 
In summary, this study has highlighted a high prevalence of heart murmurs consistent with 368 
DMVD in primary-care practices in England, with DVMD diagnosed less frequently. Survival 369 
following detection appeared good for both possible and diagnosed cases, although purebreds, 370 
larger and older dogs tended to have a less favourable prognosis. Further studies evaluating 371 
17 
 
cardiac related mortality and the predictive value of other factors including clinical and 372 
biochemical variables in primary-care practice are warranted. 373 
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Figures 473 
474 
 475 
Fig. 1 Kaplan-Meier survival curve of all-cause mortality in incident cases of diagnosed and 476 
possible degenerative mitral valve disease in dogs attending primary-care practices in 477 
England. Survival time represents the time from when the disease was initially detected until 478 
the time of death due to all-cause mortality. 479 
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 481 
Fig. 2 Kaplan-Meier survival curve of cardiac death in incident cases of diagnosed and 482 
possible degenerative mitral valve disease in dogs attending primary-care practices in 483 
England. Survival time represents the time from when the disease was initially detected until 484 
the time of death due to cardiac disease. Deaths due to other causes were censored. 485 
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Tables 487 
 488 
Table 1. Mean age at diagnosis and survival characteristics of incident cases of diagnosed and 489 
a random sample of possible degenerative mitral valve disease in dogs attending primary-care 490 
practices in the UK 491 
 Diagnosed DMVD Possible DMVDa 
Incident cases, number (%) 116 (28.6) 121 (29.7) 
Mean age in years at DMVD diagnosis / 
murmur detection (standard deviation) 
9.52 (3.20) 9.73 (4.01) 
All-cause mortality   
Deaths, number (%) 58 (50.0) 49 (40.5) 
Median survival time in months (95% CI) 25.4 (20.4 – 34.4) 33.8 (23.7 – 43.1) 
Cumulative proportion surviving at 1 year 
(95% CI) 
0.72 (0.64 – 0.80) 0.71 (0.62 – 0.79) 
Cumulative proportion surviving at 2 years 
(95% CI) 
0.55 (0.45 – 0.65) 0.57 (0.47 – 0.67) 
Cardiac related death   
Cardiac deaths, number (%) 20 (17.2) 8 (6.6) 
Median survival time in months (95% CI) n/a 42.0 (31.2 – 52.7) 
Cumulative proportion surviving at 1 year 
(95% CI) 
0.91 (0.85 – 0.97) 0.95 (0.91 – 0.99) 
Cumulative proportion surviving at 2 years 
(95% CI) 
0.84 (0.76 – 0.91) 0.93 (0.88 – 0.99) 
a Possible DMVD cases were defined as dogs over one year old with a documented heart 492 
murmur consistent with a diagnosis of DMVD without a specific cardiac diagnosis 493 
 494 
 495 
  496 
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Table 2. Descriptive statistics and univariable Cox regression analysis for risk factor 497 
association with death (all-cause mortality) among 237 incident cases with diagnosed or 498 
possible degenerative mitral valve disease attending primary-care veterinary practices. (Some 499 
variables had missing data, e.g. insurance status and bodyweight). 500 
Variable Number 
(%) 
Hazard 
ratio 
95% confidence 
interval 
P-value 
Breed     0.083 
Crossbred 43 (18.1) Baseline ~  
Cavalier King Charles Spaniel 31 (13.1) 0.44 0.21 – 0.96  
Purebred other 163  (68.8) 0.82 0.52 – 1.32  
Sex    0.403 
Female 111 (46.8) Baseline ~  
Male 126 (53.2) 0.85 0.58 – 1.24  
Insurance status    0.940 
Not insured 88 (38.8) Baseline ~  
Insured 139 (61.2) 0.98 0.65 – 1.49  
Maximum bodyweight    0.004 
<20.0 kg 163 (72.4) Baseline ~  
≥20.0 kg 62 (27.6) 1.87 1.24 – 2.83  
Age group (years)    <0.0001 
<5.0 years  27 (11.4) Baseline ~  
5.0 - <10.0 years 97 (40.9) 2.80a 2.09 – 3.75  
10.0 - <15.0 years 99 (41.8)    
≥ 15.0 years 14 (5.9)    
Level of diagnosis    0.631 
Possible DMVD 121 (51.1) Baseline ~  
Diagnosed DMVD 116 (48.9) 1.10 0.75 – 1.61  
a Hazard ratio relates to each 5 year increment in age 501 
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Table 3. Multivariable Cox regression analysis for risk factor association with death (all-503 
cause mortality) among incident cases with diagnosed or possible degenerative mitral valve 504 
disease attending primary-care veterinary practices. Observations from 225 of the 237 505 
incident cases (12 had a missing value for one of the final model variables). 506 
Variable Hazard ratio 95% confidence 
interval 
P-value 
Breed    0.053 
Crossbred Baseline ~  
Cavalier King Charles Spaniel 2.78 1.05 – 7.36  
Purebred other 1.86 1.07 – 3.23  
Maximum bodyweight   0.0001 
<20.0 kg Baseline ~  
≥20.0 kg 2.81 1.72 – 4.59  
Age group (years)   <0.0001 
<5.0 years  Baseline ~  
5.0 - <10.0 years 3.85a 2.61 – 5.69  
10.0 - <15.0 years    
≥ 15.0 years    
Level of diagnosis   0.609 
Possible DMVD Baseline ~  
Diagnosed DMVD 1.12 0.72 – 1.73  
Veterinary clinic (included as a shared frailty term) 0.027 
Theta 0.23   
a Hazard ratio relates to each 5 year increment in age 507 
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